Lobbying

GSK's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $170K. Its first report covers Q1 2025; the issues it reports most are Health Issues and Pharmacy.

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$170K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2025
The first quarter a report named it

Lobbying by quarter

GSK lobbying by quarter
GSK lobbying by quarter
QuarterAmountReports
Q1 2025$30K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Health issues$150K · 6 reports
  • Pharmacy$150K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)6 reports
  • Centers For Medicare and Medicaid Services (CMS)2 reports
  • Commerce, Dept of (DOC)2 reports
  • White House Office2 reports
  • Treasury, Dept of1 reports

Firms it paid

Firm
Checkmate Government Relations$300K6 quarters

Former officials lobbying for it

Former position
TIMOTHY LUCAS BLANCHATChief of Staff, Congressman Richard Hudson; Deputy State Director, Senator Thom TillisQ2 2026
FREDERICK VAUGHANPrincipal Deputy Asst. Secretary, Treasury Dept.; Deputy Asst. Secretary, Treasury Dept.; Senior Counsel, House Financial Services Cmte.; Associate Director, The White House; Confidential Asst., Office of Management & Budget; Writer, The White HouseQ4 2025

Lobbying reports

Filed by
07/15for Q2Checkmate Government Relations$60K
04/15for Q1Checkmate Government Relations$60K
01/20for Q4 2025Checkmate Government Relations$50K
25/10/19for Q3 2025Checkmate Government Relations$50K
25/07/20for Q2 2025Checkmate Government Relations$50K
25/04/21for Q1 2025Checkmate Government Relations$30K
25/03/14for Q1 2025Checkmate Government RelationsUnder $5,000